Improving imaging techniques for better tissue analysis with less radiation
Development of Spectral Phase Contrast Micro-CT
This study is testing a new imaging technology that helps doctors see soft tissues more clearly while using less radiation, making it safer for patients to have regular check-ups over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10830491 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technology called Spectral Phase Contrast Micro-CT, which aims to enhance the visualization of soft tissues while minimizing radiation exposure. By utilizing advanced algorithms and a specialized photon-counting detector, the researchers hope to achieve high-quality images with reduced imaging times and lower doses of radiation. This approach could allow for safer, longitudinal studies in patients, enabling better monitoring of conditions over time. The project involves collaboration between the University of Houston and a technology partner to create a unique imaging system.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients requiring frequent imaging for conditions that affect soft tissues, such as certain cancers.
Not a fit: Patients who do not require imaging or those with conditions that do not involve soft tissue may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer imaging procedures for patients, reducing their exposure to harmful radiation while improving the accuracy of tissue analysis.
How similar studies have performed: Previous research has shown promise in using phase-contrast imaging techniques, but this specific approach is innovative and aims to address existing limitations.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Das, Mini — University of Houston
- Study coordinator: Das, Mini
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.